Global Genomics Biomarkers Market Size, Status and Forecast 2019-2025

Published On: Jun 2019

Format: PDF

Publisher: QY Research

Pages: 90

Report ID: 1393

A measurable DNA and/or RNA characteristic is an indicator of normal biologic processes, pathogenic processes, and/or response to a therapeutic or other interventions. A genomic biomarker can be used for measuring the expression, function, and regulation of a gene. These biomarkers have characteristics of one or more deoxyribonucleic acid (DNA) and/or ribonucleic acid (RNA).
The increasing instances of low-cost clinical trials in developing countries will drive the growth prospects for the global genomics biomarkers market until the end of 2021. This globalization of clinical trials has been credited to numerous components that include organized trials, the willingness of members facilitating the enrollment, accessibility of qualified local investigators, enhanced opportunities in various Tier 2 and Tier 3 countries, and lower expenses of clinical trials in developing nations. Some of the other factors responsible for the increasing preference for disease-based genomic biomarkers such as cancer biomarkers testing includes the faster and precise analysis of diseases and potential lowering in volume and time involved in clinical trials.
In 2018, the global Genomics Biomarkers market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Genomics Biomarkers status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Genomics Biomarkers development in United States, Europe and China.

The key players covered in this study
Roche Diagnostics
Myriad Genetics
QIAGEN
Thermo Fisher Scientific
Bio-Rad Laboratories
...

Market segment by Type, the product can be split into
Oncology
Cardiovascular Diseases
Neurological Diseases

Market segment by Application, split into
Diagnostic and Research Laboratories
Hospitals

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Genomics Biomarkers status, future forecast, growth opportunity, key market and key players.
To present the Genomics Biomarkers development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Genomics Biomarkers are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Genomics Biomarkers Market Size Growth Rate by Type (2014-2025)
1.4.2 Oncology
1.4.3 Cardiovascular Diseases
1.4.4 Neurological Diseases
1.5 Market by Application
1.5.1 Global Genomics Biomarkers Market Share by Application (2014-2025)
1.5.2 Diagnostic and Research Laboratories
1.5.3 Hospitals
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Genomics Biomarkers Market Size
2.2 Genomics Biomarkers Growth Trends by Regions
2.2.1 Genomics Biomarkers Market Size by Regions (2014-2025)
2.2.2 Genomics Biomarkers Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Genomics Biomarkers Market Size by Manufacturers
3.1.1 Global Genomics Biomarkers Revenue by Manufacturers (2014-2019)
3.1.2 Global Genomics Biomarkers Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Genomics Biomarkers Market Concentration Ratio (CR5 and HHI)
3.2 Genomics Biomarkers Key Players Head office and Area Served
3.3 Key Players Genomics Biomarkers Product/Solution/Service
3.4 Date of Enter into Genomics Biomarkers Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Genomics Biomarkers Market Size by Type (2014-2019)
4.2 Global Genomics Biomarkers Market Size by Application (2014-2019)

5 United States
5.1 United States Genomics Biomarkers Market Size (2014-2019)
5.2 Genomics Biomarkers Key Players in United States
5.3 United States Genomics Biomarkers Market Size by Type
5.4 United States Genomics Biomarkers Market Size by Application

6 Europe
6.1 Europe Genomics Biomarkers Market Size (2014-2019)
6.2 Genomics Biomarkers Key Players in Europe
6.3 Europe Genomics Biomarkers Market Size by Type
6.4 Europe Genomics Biomarkers Market Size by Application

7 China
7.1 China Genomics Biomarkers Market Size (2014-2019)
7.2 Genomics Biomarkers Key Players in China
7.3 China Genomics Biomarkers Market Size by Type
7.4 China Genomics Biomarkers Market Size by Application

8 Japan
8.1 Japan Genomics Biomarkers Market Size (2014-2019)
8.2 Genomics Biomarkers Key Players in Japan
8.3 Japan Genomics Biomarkers Market Size by Type
8.4 Japan Genomics Biomarkers Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Genomics Biomarkers Market Size (2014-2019)
9.2 Genomics Biomarkers Key Players in Southeast Asia
9.3 Southeast Asia Genomics Biomarkers Market Size by Type
9.4 Southeast Asia Genomics Biomarkers Market Size by Application

10 India
10.1 India Genomics Biomarkers Market Size (2014-2019)
10.2 Genomics Biomarkers Key Players in India
10.3 India Genomics Biomarkers Market Size by Type
10.4 India Genomics Biomarkers Market Size by Application

11 Central & South America
11.1 Central & South America Genomics Biomarkers Market Size (2014-2019)
11.2 Genomics Biomarkers Key Players in Central & South America
11.3 Central & South America Genomics Biomarkers Market Size by Type
11.4 Central & South America Genomics Biomarkers Market Size by Application

12 International Players Profiles
12.1 Roche Diagnostics
12.1.1 Roche Diagnostics Company Details
12.1.2 Company Description and Business Overview
12.1.3 Genomics Biomarkers Introduction
12.1.4 Roche Diagnostics Revenue in Genomics Biomarkers Business (2014-2019)
12.1.5 Roche Diagnostics Recent Development
12.2 Myriad Genetics
12.2.1 Myriad Genetics Company Details
12.2.2 Company Description and Business Overview
12.2.3 Genomics Biomarkers Introduction
12.2.4 Myriad Genetics Revenue in Genomics Biomarkers Business (2014-2019)
12.2.5 Myriad Genetics Recent Development
12.3 QIAGEN
12.3.1 QIAGEN Company Details
12.3.2 Company Description and Business Overview
12.3.3 Genomics Biomarkers Introduction
12.3.4 QIAGEN Revenue in Genomics Biomarkers Business (2014-2019)
12.3.5 QIAGEN Recent Development
12.4 Thermo Fisher Scientific
12.4.1 Thermo Fisher Scientific Company Details
12.4.2 Company Description and Business Overview
12.4.3 Genomics Biomarkers Introduction
12.4.4 Thermo Fisher Scientific Revenue in Genomics Biomarkers Business (2014-2019)
12.4.5 Thermo Fisher Scientific Recent Development
12.5 Bio-Rad Laboratories
12.5.1 Bio-Rad Laboratories Company Details
12.5.2 Company Description and Business Overview
12.5.3 Genomics Biomarkers Introduction
12.5.4 Bio-Rad Laboratories Revenue in Genomics Biomarkers Business (2014-2019)
12.5.5 Bio-Rad Laboratories Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details